Budget 2023Budget 2023


  • Tata AIA Life Insurance
  • Hafele
  • Motilal Oswal
  • SMC Global Securities Limited
  • SBI Life
  • DSP Mutual Fund

Rossari Biotech: Healthy long-term prospects, but richly valued IPO

Rossari is led by technocrats having strong domain knowledge, which in turn has helped in superior execution of capex projects in the past and diversification to new end markets

July 13, 2020 / 02:28 PM IST
Rossari Biotech: Healthy long-term prospects, but richly valued IPO

Anubhav Sahu Moneycontrol Research Highlights - Largest producer of textile chemicals in India - Recent performance driven by home & personal care - Capex under way will double capacity in current fiscal - IPO size of ~Rs 500 crore, mainly an offer for sale - Expensive implied valuation of 20.6x EV/Ebitda Rossari Biotech’s Rs500 crore initial public offer (IPO) opens today. As per Frost and Sullivan, Rossari Biotech is the largest producer of textile chemicals in India and also a leading producer of acrylic polymers. The IPO issue size is in the range of...

To read the full story, Subscribe to Moneycontrol PRO

Access the exclusive stories, weekly investment ideas and daily technical calls in an Ad free experience

Already a member? Sign in

Limited Period offer on Moneycontrol PRO. Subscribe to PRO and get up to

50% OFF

What Do You Get

  • Ad free experience

    Experience a non-intrusive navigation and faster response in the ad free mode

  • Sharpest Opinions

    Access to 230+ exclusive stories per month from our editorial and Experts

  • +

    Have a Global edge with access to content from world renowned experts and journalist

  • Actionable Insights

    Access to 40+ weekly investment ideas including 4 daily technical calls

  • Virtual Events

    Exclusive access to live webinars from market experts on trading and investment strategies

  • Newsletters

    Daily and weekly insights bundled and sent to your inbox to keep you ahead in the race.

Get upto 50% discount on limited period offers